Prognostic Marker Identified for Invasive Bladder Cancer

Prognostic Marker Identified for Invasive Bladder Cancer
by Angela Mohan on 
June 1, 2021 at 12:56 PM
In the new study 32 patients developed recurrent disease and 15 patients showed progression.
A multivariate analysis revealed that non-BCG treatment was an independent risk factor for recurrence, and a higher De Ritis ratio was an independent risk factor for cancer progression.
Dr. Takashi Kawahara from The Yokohama City University Medical Center said, "Bladder cancer is the eleventh most common malignant disease in the world, and non-muscle invasive bladder cancer (NMIBC) accounts for 75% of all bladder cancer cases."
The serum aspartate aminotransaminase /alanine aminotransaminase ratio was first reported by De Ritis in 1957, since then this ratio has been called the De Ritis ratio.

Related Keywords

Yokohama ,Kanagawa ,Japan ,Takashi Kawahara ,Childrenenuresis Bedwettingcancer Factscancertattoos ,Yokohama City University Medical Center ,Oncotarget Research Output ,Health Benefits Of Dandelion Plant ,Kawahara Research Team ,High De Ritis ,Lifestyle Habits ,Homeopathyvesico Ureteric Reflux Causing ,Bedwettingcancer Factscancertattoos ,Cause Diseaseshealth Benefits ,Bladder Cancer ,Nvasive ,Prognostic Marker ,Ncotarget ,E Ritis Ratio ,Progression ,யோகோகாமா ,கனகவா ,ஜப்பான் ,யோகோகாமா நகரம் பல்கலைக்கழகம் மருத்துவ மையம் ,ஆரோக்கியம் நன்மைகள் ஆஃப் டேன்டேலியன் ஆலை ,வாழ்க்கை பழக்கம் ,சிறுநீர்ப்பை புற்றுநோய் ,